NIGERIA: NAFDAC Warns Public On Counterfeit Postinor-2 Batches in Market 

By Ameenat Hamzat, Lagos, Nigeria 

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert over falsified batches of Postinor-2 (Levonorgestrel 0.75mg), warning Nigerians about potential health risks associated with the counterfeit products.

In Public Alert No. 027/2025, NAFDAC said it received a report from the Society of Family Health (SFH) confirming that the falsified Type 1 and Type 2 batches were not imported by the company.

According to the agency, the counterfeit packs have several spelling and printing errors.

NAFDAC explained: “The font size of the text on the pin verification sticker appears smaller and wrongly spells the word Veify instead of Verify. Behind the pack, it reads “Distnibuted” in Nigeria instead of distributed in Nigeria”.

Details of the counterfeit batches were provided.

“The counterfeit has the following detail: Type 1: Batch No: T36184B, Mfg. Date: 08/2024, Exp. Date: 08/2028. Type 2: Batch No: 332, Mfg. Date: 03/2023, Exp. Date: 02/2027 while the genuine batch, is T32458H, Mfg. 02/2023, Exp. 02/2027.),” the statement highlights.

NAFDAC warned that counterfeit Postinor-2 could contain harmful substances, incorrect dosages, or toxic contaminants, posing serious risks such as contraceptive failure, allergic reactions, organ damage, or even death.

All zonal directors and state coordinators have been directed to conduct surveillance and mop up the fake products across the country.

Consumers, distributors, and healthcare providers were also urged to Buy Postinor-2 only from verified pharmacies or licensed suppliers.

The agency added that details of the alert will also be shared with the WHO Global Surveillance and Monitoring System (GSMS).